Phage-antibiotic combination: a possible approach to combatting multidrug-resistant Klebsiella pneumoniae
Abstract
Multidrug-resistant Klebsiella pneumoniae is a major global health concern due to its role in severe hospital-acquired infections and resistance to multiple antibiotics. As conventional antibiotics lose effectiveness, bacteriophage (phage) therapy offers a promising alternative. This study assessed phage therapy alone and combined with antibiotics against multidrug-resistant K. pneumoniae using the time-kill assay. A total of 48 clinical isolates were collected and identified as K. pneumoniae. According to their antibiotic susceptibility, 91.7% (n = 44) of the tested isolates were multidrug-resistant. Sewage samples were processed to isolate a phage-coded Kp25, which showed lytic activity against 17 isolates and remained stable within a temperature range of 40–90 °C and a pH range of 3–11. The taxonomic classification of the phage was made clear by the findings of the genomic analysis, which is Viruses; Duplodnaviria; Heunggongvirae; Uroviricota; Caudoviricetes; Drexlerviridae; Webervirus; Webervirus domnhall. Phage combination with sub-MIC of levofloxacin and meropenem showed potential antibacterial activity, so that complete in vitro bacterial eradication was achieved starting from 4 h incubation until the end of the incubation period. However, phage combination with sub-MIC of gentamicin showed weak antibacterial activity. These findings highlight the phage combination with levofloxacin and meropenem as an effective strategy against multidrug-resistant K. pneumoniae.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.